Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Oncotelic Therapeutics, Inc. | 378,837 | reported | 22 Jun 2026 | tx 6+1,077,093 |
| NASTECH PHARMACEUTICAL CO INC | 60,000 | reported | 02 Oct 2017 | tx 1+60,000 |
1 purchase reported after at least 12 months of silence — most recent on 22 Jun 2026.
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 22 Jun 2026 | PURCHASE | Oncotelic Therapeutics, Inc. | 20,000 | 0.05 USD | first after silence |
| 08 Jul 2021 | GRANT_AWARD | Oncotelic Therapeutics, Inc. | 298,837 | 0.00 USD | |
| 08 Jul 2021 | GRANT_AWARD | Oncotelic Therapeutics, Inc. | 698,256 | 0.00 USD | deriv |
| 20 Nov 2020 | PURCHASE | Oncotelic Therapeutics, Inc. | 31,692 | 0.20 USD | |
| 24 Nov 2020 | PURCHASE | Oncotelic Therapeutics, Inc. | 8,220 | 0.19 USD | |
| 23 Nov 2020 | PURCHASE | Oncotelic Therapeutics, Inc. | 20,088 | 0.19 USD | |
| 02 Oct 2017 | GRANT_AWARD | NASTECH PHARMACEUTICAL CO INC | 60,000 | 0.00 USD | deriv |